{"database":"ecrin-mdr-crc","file_versions":[],"scores":null,"additional":{"omics_type":["Clinical"],"study_start_year":["2019"],"condition":["Metastatic Colorectal Cancer"],"disease":["Metastatic Colorectal Cancer"],"study_type":["Interventional"],"full_dataset_link":["https://newmdr.ecrin.org/Study/2614207"],"study_start_month":["4"],"repository":["ECRIN MDR"],"study_status":["Completed"],"additional_accession":[]},"is_claimable":false,"name":"Tranexamic acid as initial treatment for unresectable metastatic colorectal cancer","description":"Interventions: Off-label use\nPrimary outcome(s): Progression-free Survival:PFS\nStudy Design: randomized controlled trial, open(masking not used), active control, parallel assignment, treatment purpose","dates":{"creation":"2019-04-15"},"accession":"2614207","cross_references":{"Japan Primary Registries Network":["JPRN-jRCTs031180417"]}}